Perspective Therapeutics to Participate at Upcoming May Investor Conferences
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-a-NET in NETs
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc. [Yahoo! Finance]
Perspective Therapeutics to Participate at Upcoming April Investor Conferences